Company performance
Add to research
Current Price
as of Apr 28, 2025$26.87
P/E Ratio
14.47
Market Cap
$863.38M
Description
Add to research
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Metrics
Add to research
Overview
- HQStoughton, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerCOLL
- Price$26.87+0.30%
Trading Information
- Market cap$863.38M
- Float96.19%
- Average Daily Volume (1m)393,462
- Average Daily Volume (3m)400,153
- EPS$2.14
Company
- Revenue$631.45M
- Rev growth (1yr)11.41%
- Net income$69.19M
- Gross margin59.76%
- EBITDA margin57.09%
- EBITDA$360.47M
- EV$1.95B
- EV/Revenue3.09
- P/E14.47
- P/S1.72
- P/B3.69
- Debt/Equity428.20
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset